A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous Ibuprofen

Trial Profile

A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous Ibuprofen

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 May 2016

At a glance

  • Drugs Ibuprofen (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions
  • Sponsors Cumberland Pharmaceuticals
  • Most Recent Events

    • 12 Jan 2015 Results published in Clinical Therapeutics.
    • 19 Feb 2013 Top-line results have been reported in a Cumberland Pharmaceuticals media release.
    • 19 Feb 2013 Status changed from recruiting to completed based on information reported in a Cumberland Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top